Protagonist Therapeutics, Inc·4

May 27, 4:01 PM ET

Williams Lewis T 4

4 · Protagonist Therapeutics, Inc · Filed May 27, 2022

Insider Transaction Report

Form 4
Period: 2022-05-26
Transactions
  • Award

    Stock Option (right to buy)

    2022-05-26+20,00020,000 total
    Exercise: $8.31Exp: 2032-05-26Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]The stock option vests in full on the earlier of (i) May 26, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service with the Issuer through such date.

Documents

1 file
  • 4
    tm2214526-5_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT